Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications
Pyrido[2,3-<i>d</i>]pyrimidines (<b>1</b>) are a type of privileged heterocyclic scaffolds capable of providing ligands for several receptors in the body. Among such structures, our group and others have been particularly interested in pyrido[2,3-<i>d</i>]pyrimidi...
| Published in: | Molecules |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-11-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/24/22/4161 |
| _version_ | 1852781045215133696 |
|---|---|
| author | Guillem Jubete Raimon Puig de la Bellacasa Roger Estrada-Tejedor Jordi Teixidó José I. Borrell |
| author_facet | Guillem Jubete Raimon Puig de la Bellacasa Roger Estrada-Tejedor Jordi Teixidó José I. Borrell |
| author_sort | Guillem Jubete |
| collection | DOAJ |
| container_title | Molecules |
| description | Pyrido[2,3-<i>d</i>]pyrimidines (<b>1</b>) are a type of privileged heterocyclic scaffolds capable of providing ligands for several receptors in the body. Among such structures, our group and others have been particularly interested in pyrido[2,3-<i>d</i>]pyrimidine-7(8<i>H</i>)-ones (<b>2</b>) due to the similitude with nitrogen bases present in DNA and RNA. Currently there are more than 20,000 structures <b>2</b> described which correspond to around 2900 references (half of them being patents). Furthermore, the number of references containing compounds of general structure <b>2</b> have increased almost exponentially in the last 10 years. The present review covers the synthetic methods used for the synthesis of pyrido[2,3-<i>d</i>]pyrimidine-7(8<i>H</i>)-ones (<b>2</b>), both starting from a preformed pyrimidine ring or a pyridine ring, and the biomedical applications of such compounds. |
| format | Article |
| id | doaj-art-3259d4a1ccd1415ca2b2a4e84df3ee5c |
| institution | Directory of Open Access Journals |
| issn | 1420-3049 |
| language | English |
| publishDate | 2019-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| spelling | doaj-art-3259d4a1ccd1415ca2b2a4e84df3ee5c2025-08-19T20:48:00ZengMDPI AGMolecules1420-30492019-11-012422416110.3390/molecules24224161molecules24224161Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical ApplicationsGuillem Jubete0Raimon Puig de la Bellacasa1Roger Estrada-Tejedor2Jordi Teixidó3José I. Borrell4Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, SpainGrup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, SpainGrup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, SpainGrup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, SpainGrup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, SpainPyrido[2,3-<i>d</i>]pyrimidines (<b>1</b>) are a type of privileged heterocyclic scaffolds capable of providing ligands for several receptors in the body. Among such structures, our group and others have been particularly interested in pyrido[2,3-<i>d</i>]pyrimidine-7(8<i>H</i>)-ones (<b>2</b>) due to the similitude with nitrogen bases present in DNA and RNA. Currently there are more than 20,000 structures <b>2</b> described which correspond to around 2900 references (half of them being patents). Furthermore, the number of references containing compounds of general structure <b>2</b> have increased almost exponentially in the last 10 years. The present review covers the synthetic methods used for the synthesis of pyrido[2,3-<i>d</i>]pyrimidine-7(8<i>H</i>)-ones (<b>2</b>), both starting from a preformed pyrimidine ring or a pyridine ring, and the biomedical applications of such compounds.https://www.mdpi.com/1420-3049/24/22/4161pyrido[2,3-<i>d</i>]pyrimidines5,6-dihydropyrido[2,3-<i>d</i>]pyrimidin-7(8<i>h</i>)-onesbiological activitysubstitution pattern |
| spellingShingle | Guillem Jubete Raimon Puig de la Bellacasa Roger Estrada-Tejedor Jordi Teixidó José I. Borrell Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications pyrido[2,3-<i>d</i>]pyrimidines 5,6-dihydropyrido[2,3-<i>d</i>]pyrimidin-7(8<i>h</i>)-ones biological activity substitution pattern |
| title | Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications |
| title_full | Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications |
| title_fullStr | Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications |
| title_full_unstemmed | Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications |
| title_short | Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications |
| title_sort | pyrido 2 3 i d i pyrimidin 7 8 i h i ones synthesis and biomedical applications |
| topic | pyrido[2,3-<i>d</i>]pyrimidines 5,6-dihydropyrido[2,3-<i>d</i>]pyrimidin-7(8<i>h</i>)-ones biological activity substitution pattern |
| url | https://www.mdpi.com/1420-3049/24/22/4161 |
| work_keys_str_mv | AT guillemjubete pyrido23idipyrimidin78ihionessynthesisandbiomedicalapplications AT raimonpuigdelabellacasa pyrido23idipyrimidin78ihionessynthesisandbiomedicalapplications AT rogerestradatejedor pyrido23idipyrimidin78ihionessynthesisandbiomedicalapplications AT jorditeixido pyrido23idipyrimidin78ihionessynthesisandbiomedicalapplications AT joseiborrell pyrido23idipyrimidin78ihionessynthesisandbiomedicalapplications |
